WAVE Life Sciences Ltd Investor Event Transcript
Hello, and welcome to the Wave Life Sciences 2022 Analyst and Investor Webcast titled Towards the Clinic: Spotlight on RNA Editing for AATD. (Operator Instructions). Please note that today's broadcast is being recorded and webcast. Following the prepared remarks, management will take questions via the phone line. (Operator Instructions) It is now my pleasure to turn today's program over to Kate Rausch.
Thank you, operator. Good morning, and thank you for joining us for this event.
The slides that accompany today's presentation will be available on the Investors section of our website at www.wavelifesciences.com. Before we begin, I would like to remind you that management may be making forward-looking statements during today's presentation. These statements are subject to a number of risks and uncertainties that could cause our actual results to differ materially from those described in these forward-looking statements. The factors
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |